"GLP-1 receptor agonists act to reduce insulin resistance by increasing glucose transporters, which in turn decreases inflammation, reduces oxidative stress, promotes insulin secretion, slows gastric emptying, and inhibits macrophage secretion of inflammatory cytokines." Mia Hudanich, Nova Southeastern University One study spanning 26 weeks revealed that a daily dose of 1.8 mg liraglutide reduced visceral adipose tissue (VAT) by 18%
Regarding side effects, some individuals experience increased heart rate, which is a known effect of these medications
When semaglutide suppresses appetite and keto eliminates an entire macronutrient category, some people end up eating 600 to 800 calories per day without realizing it
BPC-157, TB-500, and IGF-1 LR3 have no completed human trials at all
Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival